Wigren et al. explored the expression of tissue degradation markers in systemic lupus erythematosus (SLE) patients with or without cardiovascular disease, the results showed that the level of MMP1 in SLE patients with cardiovascular disease was higher than that in SLE patients without cardiovascular disease (31). The gene discussed is MMP1; the disease is cardiovascular disorder.